QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Nestler, E. J. Search for Related Content PubMed PubMed Citation Articles by Nestler, E. J. Pubmed/NCBI databases Medline Plus Health Information Drug Abuse

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 1, 2001, 21(21):8324-8327

Psychogenomics: Opportunities for Understanding Addiction

Eric J. Nestler

Department of Psychiatry and Center for Basic Neuroscience, The University of Texas Southwestern Medical Center, Dallas, Texas 75390-9070

The term psychogenomics is used here to describe the process of applying the powerful tools of genomics and proteomics to achieve a better understanding of the biological substrates of normal behavior and of diseases of the brain that manifest themselves as behavioral abnormalities. Applying psychogenomics to the study of drug addiction will lead to the identification of genes and their protein products that control the reward pathways of the brain and their adaptations to drugs of abuse, as well as variations in these genes that confer genetic risk for addiction and related disorders. The ultimate goal is to use this information to develop more effective treatments for these disorders as well as objective diagnostic tools, preventive measures, and eventually cures.

---

Copyright © 2001 Society for Neuroscience  0270-6474/01/21218324-04$05.00/0

This article has been cited by other articles:

				J.-K. Zubieta, M. M. Heitzeg, Y. R. Smith, J. A. Bueller, K. Xu, Y. Xu, R. A. Koeppe, C. S. Stohler, and D. Goldman COMT val158met Genotype Affects {micro}-Opioid Neurotransmitter Responses to a Pain Stressor Science, February 21, 2003; 299(5610): 1240 - 1243. [Abstract] [Full Text] [PDF]

				F. J. White A Behavioral/Systems Approach to the Neuroscience of Drug Addiction J. Neurosci., May 1, 2002; 22(9): 3303 - 3305. [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help